IceCure Medical Ltd

NasdaqCM:ICCM Stock Report

Market Cap: US$53.5m

IceCure Medical Past Earnings Performance

Past criteria checks 0/6

IceCure Medical's earnings have been declining at an average annual rate of -35%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 14.8% per year.

Key information

-35.0%

Earnings growth rate

-6.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate14.8%
Return on equity-120.5%
Net Margin-453.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Nov 29
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate

Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

Aug 08
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?

IceCure gains 19% on seeking FDA nod for cancer treatment

Oct 19

IceCure files application for approval of ProSense in Canada for tumors

Jul 25

IceCure Medical: Advancing Cryotherapy For Cancer Treatment

Jan 25

Revenue & Expenses Breakdown
Beta

How IceCure Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:ICCM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233-1598
30 Sep 233-1699
30 Jun 233-1699
31 Mar 233-1699
31 Dec 223-1799
30 Sep 224-1698
30 Jun 224-1598
31 Mar 223-1387
31 Dec 214-1066
30 Sep 214-856
30 Jun 214-645
31 Mar 214-434
31 Dec 204-434
30 Sep 203-433
30 Jun 203-433
31 Mar 202-423
31 Dec 192-523
30 Sep 191-523
30 Jun 191-422
31 Mar 191-422
31 Dec 181-422
30 Sep 181-322
30 Jun 181-312
31 Mar 181-312
31 Dec 171-311
30 Sep 171-312
30 Jun 171-312
31 Mar 171-312
31 Dec 161-322
30 Sep 161-321
30 Jun 161-421
31 Mar 161-431
31 Dec 151-431
30 Sep 151-431
30 Jun 151-431
31 Mar 151-431
31 Dec 141-531
30 Sep 141-531
30 Jun 141-531
31 Mar 140-531
31 Dec 130-531
30 Sep 130-531
30 Jun 130-531

Quality Earnings: ICCM is currently unprofitable.

Growing Profit Margin: ICCM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ICCM is unprofitable, and losses have increased over the past 5 years at a rate of 35% per year.

Accelerating Growth: Unable to compare ICCM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ICCM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).


Return on Equity

High ROE: ICCM has a negative Return on Equity (-120.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.